Back | Next |
home / stock / nltx / nltx message board
Subject | By | Source | When |
---|---|---|---|
thank you good repore' $nltx | mick | investorshub | 01/05/2022 2:30:14 AM |
https://www.geekwire.com/2021/biosensor-startup-monod-lands-6m-and-spins-out-of-univ-of-washingtons- | Phosphene | investorshub | 01/05/2022 2:03:45 AM |
https://www.otcmarkets.com/stock/$NLTX | mick | investorshub | 01/02/2022 10:05:18 PM |
https://www.otcmarkets.com/stock/$NLTX | mick | investorshub | 12/11/2021 10:01:36 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 11/06/2021 4:25:10 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 10/08/2021 3:06:57 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 09/22/2021 11:28:09 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 08/14/2021 4:28:29 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 07/11/2021 3:31:45 AM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 07/08/2021 6:08:17 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 05/26/2021 3:43:54 PM |
www.stockscores.com/chart.asp?TickerSymbol=NLTX&TimeRange=275&Interval=d& | mick | investorshub | 05/02/2021 10:12:08 PM |
www.stockscores.com/chart.asp?TickerSymbol=NLTX&TimeRange=275&Interval=d& | mick | investorshub | 05/02/2021 10:12:07 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 04/18/2021 4:33:51 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 02/21/2021 12:13:45 AM |
https://otcbb.swingtradebot.com/equities/$NLTX N.Y. , NASDAQ | mick | investorshub | 02/01/2021 1:24:20 AM |
me again o.k. | mick | investorshub | 01/15/2021 12:07:35 AM |
Well, since you're asking... erm... a few thousand | Schrogtergracht | investorshub | 01/15/2021 12:00:47 AM |
thank you, any other business ????? | mick | investorshub | 01/14/2021 11:56:45 PM |
Thanks for trying, mick. P.S. The all | Schrogtergracht | investorshub | 01/14/2021 11:54:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Neoleukin Therapeutics Inc. Company Name:
NLTX Stock Symbol:
NYSE Market:
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023